Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SunPenguin
    Member
    • Aug 2015
    • 38

    #1

    Running BioA on RNA/cDNA samples in lysis/RT buffer

    Hi all,

    I have done some RNA-seq on relatively large samples (cell count wise) before, so I never really had to run bioA on unpurified samples before.

    Now, however, I'm starting to sort low number of cells (100-1000) into lysis buffer (5uL), and I would like to quantify the RNA and/or the cDNA I get from a TSO RT (like SMART-seq2 or SMARTer seq). Or, I would at least like to get some idea of RNA integrity and cDNA sizes

    I tried to run the whole lysate on a RNA pico chip (so the RNA is in lysis buffer), and the 28/18S peaks came out weird (attached). The peaks seem to come out at much larger sizes, and not exactly consistent from sample to sample either. Is that due to the salt in the solution? or is that just mechanical error?

    Also, how should I run cDNA on the bioA? Some people tell me to run it on an RNA chip, since cDNA (after 1st strand synthesis) should be single stranded. Do I also need to treat the sample with RNAse H? and how about the carry over RNA from the 1st strand reaction? (assuming if I don't want to purify my cDNA out of the 1st strand buffer, since I am assuming the concentration is low)

    Any help would be greatly appreciated!
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 02:55 AM
0 responses
5 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...